LEADING ARTICLE
Parenchymal liver disease in the elderly
| The first 150 words of the full text of this article appear below. |
| |
Introduction |
|---|
Until recently, the subject of parenchymal liver disease
presenting in elderly patients had received little specific attention. Many studies have examined changes in morphology and function in the
aging liver, initially in rodents and subsequently in humans. In
summary, there are no age specific alterations in conventional liver
biochemistry (serum bilirubin, serum aminotransferases, hepatic
alkaline phosphatase, and other liver blood tests) but a number of
dynamic measurements of liver function do decline from early adulthood
to senescence.1 Liver size, liver blood flow and liver
perfusion decline between the third and tenth decades by
30-40%.2 Most reflections of dynamic liver
function
galactose elimination, aminopyrine demethylation, or caffeine
clearance
fall pari passu with the reduction in liver volume and blood
flow.3 4
Conceivably, some specific liver functions
for
example, hepatic nitrogen clearance, are independently impaired, in
this case by up to 50% with advancing age.5 It is
probably in the area of liver
Relevant Article
- Aging and the alimentary tract
- MICHAEL FARTHING and OLIVER JAMES
Gut 1997 41: 421.[Extract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
